Targeted glycophagy ATG8 therapy reverses diabetic heart disease in mice and in human engineered cardiac tissues

Overview of attention for article published in Nature Cardiovascular Research, September 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news: 3 news outlets
blogs: 2 blogs
twitter: 4 X users

reddit: 1 Redditor
bluesky: 7 Bluesky users

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 10,843 followers.

RT @NatureCVR: Research | Deficiency of GAPARAPL1 impairs diastolic function in diabetic mice. This effect can be reversed by gene delivery…

Research | Deficiency of GAPARAPL1 impairs diastolic function in diabetic mice. This effect can be reversed by gene delivery of the gene encoding GABARAPL1 in diabetic mice and in human organoids of type 2 diabetes. @DelbridgeLab https://t.co/ciUNzuYnbs…

RT @KimMellor_UAkl: 🫀 Excited to share our new study published this week in Nature Cardiovascular Research identifies a promising new thera…

🫀 Excited to share our new study published this week in Nature Cardiovascular Research identifies a promising new therapeutic target for diabetic heart disease. 🔗 https://t.co/5c5xT6EDQq Funded by HRC & @MarsdenFund

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.